Inventor · disambiguated record
Maria Del Pilar Molina-Portela
Also filed as: MOLINA-PORTELA MARIA DEL PILAR
6 granted patents·4 pending applications·5 citations·filing 2020–2024
75Inventor score
Technology areasA61K
Files withREGENERON PHARMA10
Top patents by PatentIndex Score
10 records- 0195US11725034B2IL2 agonists and methods of use thereofREGENERON PHARMA·Filed 2022·Granted Aug 15, 2023·4 cites·30 claims
- 0288US2024400632A1Novel il2 agonists and methods of use thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0387US12091440B2IL2 and peptide-MHC complex fusion proteins and methods of use thereofREGENERON PHARMA·Filed 2020·Granted Sep 17, 2024·1 cites·33 claims
- 0487US2025034224A1Novel il2 agonists and methods of use thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0585US12215131B2IgG Fc-IL2-Rα-IL2 fusions and methods of use thereofREGENERON PHARMA·Filed 2023·Granted Feb 4, 2025·0 cites·25 claims
- 0683US2023312665A1Novel il2 agonists and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0781US12319724B2IL2 agonists and methods of use thereofREGENERON PHARMA·Filed 2022·Granted Jun 3, 2025·0 cites·13 claims
- 0879US12187772B2IL10 agonists and methods of use thereofREGENERON PHARMA·Filed 2023·Granted Jan 7, 2025·0 cites·31 claims
- 0977US2025333464A1Il10 agonists and methods of use thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1070US11673930B2IL10 agonists and methods of use thereofREGENERON PHARMA·Filed 2021·Granted Jun 13, 2023·0 cites·24 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →